Rong Tao
Clinical trials sponsored by Rong Tao, explained in plain language.
-
New combo attack on rare blood cancer shows promise in early trial
Disease control Recruiting nowThis study tests two drugs, tislelizumab and zeprumetostat, together in people with a rare type of lymphoma that has come back or not responded to treatment. About 107 adults will take part to see if the combination is safe and shrinks tumors. The goal is to control the cancer, n…
Phase: PHASE1, PHASE2 • Sponsor: Rong Tao • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to wipe out lingering lymphoma cells after remission
Disease control Recruiting nowThis phase 2 trial tests a drug called chidamide in people with a type of aggressive lymphoma (double-expressor DLBCL) who are in remission but still have traces of cancer DNA in their blood. The goal is to see if taking chidamide pills for up to two years can clear those hidden …
Phase: PHASE2 • Sponsor: Rong Tao • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC